Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustaqeem

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
American Journal of Hematology|March 5, 2020
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemiaLaura A Evans, Dragan Jevremovic, Bharat Nandakumar, et al.
Blood Cancer Journal|December 14, 2020
Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patientsAlissa Visram, Abdullah S Al Saleh, Harsh Parmar, et al.
American Journal of Hematology|October 28, 2021
Prognostic significance of acquired 1q22 gain in multiple myelomaHadiyah Y Audil, Joselle M Cook, Patricia T Greipp, et al.
Blood Cancer Journal|June 8, 2021
Correction: MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patientsPatrick W Mellors, Surendra Dasari, Mindy C Kohlhagen, et al.
Blood Cancer Journal|March 5, 2021
MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patientsPatrick W Mellors, Surendra Dasari, Mindy C Kohlhagen, et al.
Blood Cancer Journal|December 27, 2025
Impact of t(11;14) primary cytogenetic abnormality and the cumulative effect of multiple high-risk cytogenetics at diagnosis on the outcomes of patients with primary plasma cell leukemiaTamer Hellou, Shaji K Kumar, Samhar Samer Alouch, et al.
American Journal of Hematology|June 4, 2026
Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell LeukemiaDaniel G Packard, Shaji K Kumar, Angela Dispenzieri, et al.
Blood Cancer Journal|April 14, 2022
Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS)Jacqui-Lyn Saw, M Hasib Sidiqi, Michael Ruff, et al.
Blood Cancer Journal|February 1, 2022
A simple additive staging system for newly diagnosed multiple myelomaNadine H Abdallah, Moritz Binder, S Vincent Rajkumar, et al.
Blood Advances|April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL AmyloidosisMaximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
American Journal of Hematology|March 5, 2020
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemiaLaura A Evans, Dragan Jevremovic, Bharat Nandakumar, et al.
Blood Cancer Journal|December 14, 2020
Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patientsAlissa Visram, Abdullah S Al Saleh, Harsh Parmar, et al.
American Journal of Hematology|October 28, 2021
Prognostic significance of acquired 1q22 gain in multiple myelomaHadiyah Y Audil, Joselle M Cook, Patricia T Greipp, et al.
Blood Cancer Journal|June 8, 2021
Correction: MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patientsPatrick W Mellors, Surendra Dasari, Mindy C Kohlhagen, et al.
Blood Cancer Journal|March 5, 2021
MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patientsPatrick W Mellors, Surendra Dasari, Mindy C Kohlhagen, et al.
Blood Cancer Journal|December 27, 2025
Impact of t(11;14) primary cytogenetic abnormality and the cumulative effect of multiple high-risk cytogenetics at diagnosis on the outcomes of patients with primary plasma cell leukemiaTamer Hellou, Shaji K Kumar, Samhar Samer Alouch, et al.
American Journal of Hematology|June 4, 2026
Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell LeukemiaDaniel G Packard, Shaji K Kumar, Angela Dispenzieri, et al.
Blood Cancer Journal|April 14, 2022
Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS)Jacqui-Lyn Saw, M Hasib Sidiqi, Michael Ruff, et al.
Blood Cancer Journal|February 1, 2022
A simple additive staging system for newly diagnosed multiple myelomaNadine H Abdallah, Moritz Binder, S Vincent Rajkumar, et al.
Blood Advances|April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL AmyloidosisMaximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Pageof 16